Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Colasanti

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2020
Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical TrialJeffrey H Samet, Judith I Tsui, Debbie M Cheng, et al.
AIDS Research and Human Retroviruses|July 3, 2024
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. SouthGrace C Haser, Laurence Balter, Stephen Gurley, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2025
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experimentJose I Gutierrez, Elizabeth T Montgomery, Samantha E Dilworth, et al.
Open Forum Infectious Diseases|August 8, 2022
Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018Jun Li, Elizabeth Humes, Jennifer S Lee, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2021
Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORDYuhang Qian, Richard D Moore, Sally B Coburn, et al.
The Journal of Infectious Diseases|November 29, 2023
Multisite Mpox Infection and Viral Dynamics Among Persons With HIV in Metro AtlantaGregory L Damhorst, A Wendy Fujita, Eric Fitts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018Thibaut Davy-Mendez, Sonia Napravnik, Brenna C Hogan, et al.
BMJ Medicine|May 21, 2025
Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling studyHenock G Yebyo, Huldrych F Guenthard, Eva A Rehfuess, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2020
Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical TrialJeffrey H Samet, Judith I Tsui, Debbie M Cheng, et al.
AIDS Research and Human Retroviruses|July 3, 2024
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. SouthGrace C Haser, Laurence Balter, Stephen Gurley, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2025
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experimentJose I Gutierrez, Elizabeth T Montgomery, Samantha E Dilworth, et al.
Open Forum Infectious Diseases|August 8, 2022
Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018Jun Li, Elizabeth Humes, Jennifer S Lee, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2021
Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORDYuhang Qian, Richard D Moore, Sally B Coburn, et al.
The Journal of Infectious Diseases|November 29, 2023
Multisite Mpox Infection and Viral Dynamics Among Persons With HIV in Metro AtlantaGregory L Damhorst, A Wendy Fujita, Eric Fitts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018Thibaut Davy-Mendez, Sonia Napravnik, Brenna C Hogan, et al.
BMJ Medicine|May 21, 2025
Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling studyHenock G Yebyo, Huldrych F Guenthard, Eva A Rehfuess, et al.
Pageof 17